micro-community-banner
 
  • Saved
A rare association: Obesity hypoventilation syndrome with myasthenia gravis and systemic lupus erythematosus, case report

A rare association: Obesity hypoventilation syndrome with myasthenia gravis and systemic lupus erythematosus, case report

Source : https://www.sciencedirect.com/science/article/pii/S2213007123000436?via=ihub

Author links open overlay panel Safwat Eldaabossi a b , , , , , , , , , , , , , Show more Shrinking lung syndrome (SLS) is an...

Conclusion: The interesting aspect of this case report: is the presentation of the overlap of obesity hypoventilation syndrome and shrinking lung syndrome due to systemic lupus erythematosus with generalized and respiratory muscle dysfunction due to myasthenia gravis with good outcomes after therapy.
 

  • Saved
Clinical and immune-related factors associated with exacerbation in adults with well-controlled generalized myasthenia gravis

Clinical and immune-related factors associated with exacerbation in adults with well-controlled generalized myasthenia gravis

Source : https://www.frontiersin.org/articles/10.3389/fimmu.2023.1177249/full

ObjectivesTo describe the clinical predictors and immune-related factors for exacerbation in adults with well-controlled generalized myasthenia gravis (GMG).MethodsWe conducted a retrospective analysis of 585 adults with well-controlled GMG from our...

Conclusion: Myasthenia gravis (MG) exacerbations were more frequent in those patients with older onset age, longer disease duration, more severe MGFA classification, positive AChR-ab, and lack of combined immunotherapy or thymectomy treatment. On the other hand, CD3–CD19+ B cells, CD3+CD8+ T cells, Tregs, and AChR-ab in peripheral blood may...

  • Saved

Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study

Source : https://www.frontiersin.org/articles/10.3389/fimmu.2023.1141983/full

BackgroundThe safety of COVID-19 vaccines has been clarified in clinical trials; however, some immunocompromised patients, such as myasthenia gravis (MG) patients, are still hesitant to receive vaccines. Whether COVID-19 vaccination...

Conclusion: COVID-19 vaccination has no long-term impact on MG relapse.

  • Saved
Circulating CXCR5+ natural killer cells are expanded in patients with myasthenia gravis - PubMed

Circulating CXCR5+ natural killer cells are expanded in patients with myasthenia gravis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37223338/

The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....

Conclusion: These results reveal that CXCR5+ NK cells exhibit distinct phenotypes and functions compared with CXCR5− NK cells and might participate in the pathogenesis of MG.
 

  • Saved
Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM Study - PubMed

Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM Study - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37233280/

An altered gut microbiota is a possible contributing pathogenic factor in myasthenia gravis (MG), an autoimmune neuromuscular disease. However, the significance of the fungal microbiome is an understudied and neglected...

Conclusions/Relevance: Besides one MG patient with abundant Ca. albicans, no prominent dysbiosis in the MG group of the mycobiome was found. Not all fungal sequences within all groups were successfully assigned, so further sub-analysis was withdrawn, limiting robust conclusions.